Showing results (2171-2180 of 8,887) with videos related to
Sort By:
Pageof 889
European Urology|July 17, 2010
Nodal staging in penile carcinoma by dynamic sentinel node biopsy after previous therapeutic primary tumour resectionNiels M Graafland, Renato A Valdés Olmos, Willem Meinhardt, et al.European Urology|August 3, 2010
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?Giacomo Novara, Vincenzo Ficarra, Alessandro Antonelli, et al.European Urology|July 8, 2010
Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancerChunyang Wang, Weiyang Tao, Youdong Wang, et al.European Urology|May 18, 2010
Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumoursChristine Mian, Guido Mazzoleni, Silke Vikoler, et al.European Urology|September 17, 2010
Words of wisdom. Re: Effect of dutasteride on the risk of prostate cancer. Andriole G, Bostwick D, Brawley O, et al. N Engl J Med 2010;362:1192-202Laurence KlotzEuropean Urology|September 17, 2010
Words of wisdom. Re: Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles. Maxeiner A, Adkins CB, Zhang Y, et al. Prostate 2010;70:710-7Alessandro SciarraEuropean Urology|September 7, 2010
Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrenceNicola Nicolai, Rosalba Miceli, Andrea Necchi, et al.European Urology|September 7, 2010
Hereditary renal cancer syndromes: an update of a systematic reviewJérôme Verine, Amélie Pluvinage, Guilhem Bousquet, et al.European Urology|August 31, 2010
Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatmentMark S Soloway, Cynthia T Soloway, Ahmed Eldefrawy, et al.European Urology|September 11, 2010
Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trialsAxel Bex, Eric Jonasch, Ziya Kirkali, et al.Pageof 889